Search research articles
Contact Us
Filters
Showing results (41-50 of 335) with videos related to
Page
of 34
Sort By:
Human Vaccines & Immunotherapeutics
|
April 21, 2021
Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials
Melissa Bersanelli, Fausto Petrelli, Sebastiano Buti, et al.
BMC Cancer
|
August 14, 2016
Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report
Paola Bordi, Marcello Tiseo, Giorgio Baldari, et al.
Oncology Reviews
|
May 21, 2015
Systemic adjuvant therapies in renal cell carcinoma
Sebastiano Buti, Melissa Bersanelli, Maddalena Donini, et al.
Seminars in Oncology
|
November 16, 2019
A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
Alessio Cortellini, Sebastiano Buti, Veronica Agostinelli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2021
Response to letter entitled: Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy
Alessio Cortellini, Melissa Bersanelli, David J Pinato, et al.
Minerva Urology and Nephrology
|
December 21, 2023
Wolf in sheep's clothing or not? The pT1 LG dilemma
Giulia C Giudice, Davide Campobasso, Umberto Maestroni, et al.
Therapeutic Advances in Medical Oncology
|
June 20, 2020
Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review
Melissa Bersanelli, Matteo Brunelli, Letizia Gnetti, et al.
Current Drug Targets
|
January 14, 2016
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report
Melissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, et al.
Annals of Translational Medicine
|
April 30, 2019
Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptions
Melissa Bersanelli, Sebastiano Buti, Matteo Santoni, et al.
Anti-Cancer Drugs
|
January 10, 2020
A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?
Melissa Bersanelli, Sebastiano Buti, Antonio Ghidini, et al.
Page
of 34
Search research articles
Search
Showing results (41-50 of 335) with videos related to
Sort By:
Page
of 34
Human Vaccines & Immunotherapeutics
|
April 21, 2021
Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials
Melissa Bersanelli, Fausto Petrelli, Sebastiano Buti, et al.
BMC Cancer
|
August 14, 2016
Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report
Paola Bordi, Marcello Tiseo, Giorgio Baldari, et al.
Oncology Reviews
|
May 21, 2015
Systemic adjuvant therapies in renal cell carcinoma
Sebastiano Buti, Melissa Bersanelli, Maddalena Donini, et al.
Seminars in Oncology
|
November 16, 2019
A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
Alessio Cortellini, Sebastiano Buti, Veronica Agostinelli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2021
Response to letter entitled: Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy
Alessio Cortellini, Melissa Bersanelli, David J Pinato, et al.
Minerva Urology and Nephrology
|
December 21, 2023
Wolf in sheep's clothing or not? The pT1 LG dilemma
Giulia C Giudice, Davide Campobasso, Umberto Maestroni, et al.
Therapeutic Advances in Medical Oncology
|
June 20, 2020
Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review
Melissa Bersanelli, Matteo Brunelli, Letizia Gnetti, et al.
Current Drug Targets
|
January 14, 2016
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report
Melissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, et al.
Annals of Translational Medicine
|
April 30, 2019
Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptions
Melissa Bersanelli, Sebastiano Buti, Matteo Santoni, et al.
Anti-Cancer Drugs
|
January 10, 2020
A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?
Melissa Bersanelli, Sebastiano Buti, Antonio Ghidini, et al.
Page
of 34